Press Releases Items Per Page 102550 Year None202520242023202220212020201920182017201620152014 12-01-2025 Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization 11-24-2025 Daré Bioscience Receives $3.6 Million in Additional Grant Funding 11-13-2025 Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update 11-11-2025 Daré Bioscience Highlights Commercial Launch Readiness for DARE to PLAY™ Sildenafil Cream; November 17th Webinar to Feature Leading Clinicians Discussing Clinical Data and Potential Impact in Women’s Sexual Health 11-06-2025 Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025 11-03-2025 Daré Bioscience to Receive up to $300,000 to Conduct Global Contraceptive Innovation Capabilities Landscape Assessment 10-06-2025 Daré Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders 09-24-2025 Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research 08-14-2025 Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update 08-07-2025 Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025 Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 26
12-01-2025 Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization
11-13-2025 Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11-11-2025 Daré Bioscience Highlights Commercial Launch Readiness for DARE to PLAY™ Sildenafil Cream; November 17th Webinar to Feature Leading Clinicians Discussing Clinical Data and Potential Impact in Women’s Sexual Health
11-06-2025 Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025
11-03-2025 Daré Bioscience to Receive up to $300,000 to Conduct Global Contraceptive Innovation Capabilities Landscape Assessment
10-06-2025 Daré Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders
08-14-2025 Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
08-07-2025 Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
